FDA Accepts for Priority Review Ascendis Pharma’s NDA for TransCon™ PTH in Adult Patients with Hypoparathyroidism

Ascendis Pharma A/S Announces Phase 3 PaTHway Trial of TransCon^TM PTH in Adults with Hypoparathyroidism Met Primary and All Key Secondary Endpoints

Ascendis Pharma A/S Receives European Approval for TransCon^TM hGH for Pediatric Growth Hormone Deficiency

每周给药一次注射用隆培促生长素（当地商品名：SKYTROFA^®，国内商品名正在注册中）于美国当地时间8月25日宣布获得美国食品和药品监督管理局（FDA）批准，用于治疗一岁以上…